The Pharmacist
NOVEMBER 14, 2024
Community pharmacy leaders across the sector have called for uplifted funding to stop pharmacy closures and ease pressures, stressing that the current arrangements are putting patient safety at risk. This comes as the National Pharmacy Association (NPA) announced that 99% of participating pharmacy owners voted to limit their services unless funding is improved.
STAT
NOVEMBER 14, 2024
As a medical intern in the late 1980s, I’d occasionally see priests and rabbis on hospital wards, but we basically ignored one another. When we doctors walked into a patient’s room, they’d quickly leave, and when we exited, they’d enter. They seemed to operate in a wholly different realm. After all, we were scientific.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharmacist
NOVEMBER 14, 2024
The government has urged pharmacies to work with ministers to achieve 'a service fit for the future', following a vote by pharmacy owners in favour of collective action. The Department of Health and Social Care said it was 'committed to working with the sector and would encourage all pharmacists to work with us'. This comes […] The post Government encourages pharmacists to 'work with us' appeared first on The Pharmacist.
STAT
NOVEMBER 14, 2024
The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceutical company to task for its marketing. The regulator criticized Merz for a few reasons concerning Xeomin, which is promoted as an alternative to Botox for combating wrinkle and frown lines.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Safe Biologics
NOVEMBER 14, 2024
SAVE THE DATE: ASBM and GaBI to Present Webinar on the Biosimilar Red Tape Elimination Act October 31st On October 31st, ASBM and the Generics and Biosimilar Initiative will present a webinar focusing Senate Bill 2305, the Biosimilar Red Tape Elimination Act. Health policy experts will review current U.S. biosimilar approval and substitution policies, discuss the rationale behind them, and examine the potential consequences of the proposed changes.
STAT
NOVEMBER 14, 2024
Why are AbbVie executives feeling the M&A blues? What does it take to slice $12 billion from Amgen’s market value? And why are STAT’s D.C. correspondents working so hard? We talk about all that and more on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. It’s a “Chatty Cathy” episode!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
NOVEMBER 14, 2024
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it’s a good time to correct one of the more egregious misconceptions regarding the handling of patient subgroup data that has been floating persistently around the internet.
European Pharmaceutical Review
NOVEMBER 14, 2024
BioNTech SE has agreed to acquire Biotheus and will gain rights to the biotech’s in-house bispecific antibody drug conjugate (ADC) capability and pipeline candidates. Specifically, BioNTech will obtain worldwide access to the late-stage PD-L1 x VEGF-A-targeting bispecific antibody BNT327/PM8002. This treatment, in combination with BNT325/DB-1305, a Trophoblast Cell-Surface Antigen 2 (“TROP2”)-targeted ADC candidate is being evaluated in an ongoing Phase I/II clinical trial.
STAT
NOVEMBER 14, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’m back on the newsletter beat today while Theresa’s on holiday, but I’m off to Chicago soon to cover the American Heart Association’s scientific sessions. Ping me if you’ll be following the conference, too.
PharmaVoice
NOVEMBER 14, 2024
While Martin Shkreli smirked his way through a public securities fraud investigation, Ron Tilles became interim CEO of Turing Pharmaceuticals, ready or not. Here’s his story.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 14, 2024
Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company shuts down, and a deep dive on digital measures for tracking disease.
pharmaphorum
NOVEMBER 14, 2024
There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn't left behind. Its solution is a licensing deal with Chinese biotech LaNova Medicines for LM-299, which consists of an anti-VEGF antibody joined to the functional parts of a pair of anti-PD-1 antibodies.
FDA Law Blog: Biosimilars
NOVEMBER 14, 2024
By Jennifer D. Newberger — “An open foe may prove a curse, but a pretended friend is worse.” When the poet John Gay wrote these words in 1727, the idea of an administrative agency like the FDA was likely the furthest thing from his mind. That he is now being quoted in a blog post to discuss the relationship between medical device companies and their regulatory oversight body shows that some ideas really do have staying power.
Pharma Times
NOVEMBER 14, 2024
Therapy shows high efficacy in initial trial phase
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
BioPharma Dive
NOVEMBER 14, 2024
The company is paying China-based biotech LaNova Medicines $588 million for the type of dual-pronged antibody drug that recently bested Keytruda in a clinical trial.
Pharma Times
NOVEMBER 14, 2024
First participant vaccinated in study of ovx836 booster dose
BioPharma Dive
NOVEMBER 14, 2024
A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.
Pharma and Life Sciences Blog
NOVEMBER 14, 2024
GEP Outlook 2025 priyanka.katke… Thu, 11/14/2024 - 14:45 Drive Procurement and Supply Chain Success in 2025 For years, you and your team have fought an uphill battle. Supply disruptions. Cost pressures. ESG compliance. Geopolitical tensions. You name it, and you’ve had to navigate it. In 2025, many challenges will persist, but procurement and supply chain teams have a powerful tool with rapidly advancing capabilities to tackle them — artificial intelligence (AI).
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
NOVEMBER 14, 2024
GSK's multiple myeloma therapy Blenrep's increase in overall survival in the DREAMM-7 trial has achieved statistical significance
World Pharma News
NOVEMBER 14, 2024
The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency.
Outsourcing Pharma
NOVEMBER 14, 2024
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.
Pharmaceutical Technology
NOVEMBER 14, 2024
The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene therapy in the US that is directly delivered to the brain.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Putting Patients First Blog
NOVEMBER 14, 2024
NHC Fall International Patient Forum Event Time: 1:00 - 2:30 p.m. ET Event Location: Virtual Home Register About the Event The NHC International Patient Forum (IPF) builds awareness and capacity in the U.S. patient community to be better informed, involved, and influential in international discussions and decision-making. The IPF offers all NHC members the opportunity to share information and strategic thinking on international issues affecting patient health and well-being.
Pharmaceutical Technology
NOVEMBER 14, 2024
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
pharmaphorum
NOVEMBER 14, 2024
Syncona launches Slingshot Therapeutics with a mission to find promising projects in academia and translate them into development projects.
Pharmaceutical Technology
NOVEMBER 14, 2024
Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Script
NOVEMBER 14, 2024
Our team at Rx relief explains the "Warm Body" hiring mistake & how you can avoid making it going forward.
Outsourcing Pharma
NOVEMBER 14, 2024
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.
BioPharma Dive
NOVEMBER 14, 2024
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review voucher for PTC.
Outsourcing Pharma
NOVEMBER 14, 2024
Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to type 2 diabetes in 99% of participants.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
124 
Let's personalize your content